| Announce Date | 11/06/2025 |
| EPS Normalized Actual | $0.1643 (Beat by $0.0243) |
| EPS GAAP Actual | $0.1643 (Beat by $0.0243) |
| Revenue Actual | $0.3032B |
| Revenue Surprise | Beat by $303.2M |
| Announce Date | 03/30/2026 (Pre-Market) |
| EPS Normalized Estimate | $0.16335 |
| EPS GAAP Estimate | $0.16335 |
| Revenue Estimate | $0.334394289B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 1.28743 | 12.51 | 1.25052 | 1.31774 | 1 |
| Dec 2028 | 1.04244 | 15.44 | 1.03145 | 1.05257 | 3 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.13 | -0.02613 | 0.3032B | 8.36% | -8.94M |
| FQ2 2025 (Jun 2025) | 0.11 | 0.11 | 0.280037B | 6.83% | 280.04M |
| FQ1 2025 (Mar 2025) | 0.0911 | 0.0911 | 0.256596B | 7.49% | 256.6M |
| FQ4 2024 (Dec 2024) | 0 | 0 | 0.330595B | 5.51% | 330.6M |
| FQ3 2024 (Sep 2024) | 0.11 | 0.11 | 0.277867B | 2.33% | 277.87M |
| FQ2 2024 (Jun 2024) | 0.0759 | 0.0759 | 0.260913B | 2.15% | 260.91M |
| FQ1 2024 (Mar 2024) | 0.0712 | 0.0712 | 0.237383B | -0.26% | 237.38M |
| FQ4 2023 (Dec 2023) | 0.17 | 0.17 | 0.312374B | 100% | 312.37M |
FQ4 Announce Date
03/30/2026 (Pre-Market)
Consensus EPS Estimates
0.16335
Consensus Revenue Estimates
0.334394289B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.29787 | -- | 0.29309 | 0.30195 | 2 |
| FQ3 2027 (Sep 2027) | 0.21987 | -- | 0.2125 | 0.22863 | 1 |
| FQ2 2027 (Jun 2027) | 0.17424 | -- | 0.1684 | 0.18118 | 1 |
| FQ1 2027 (Mar 2027) | 0.1793 | -- | 0.17642 | 0.18176 | 2 |
| FQ4 2026 (Oct 2026) | 0.21775 | -- | 0.20104 | 0.22807 | 3 |
| FQ3 2026 (Jul 2026) | 0.17888 | 27.33 | 0.16516 | 0.18735 | 3 |
| FQ2 2026 (Jun 2026) | 0.21556 | 48.97 | 0.20913 | 0.23557 | 3 |
| FQ1 2026 (Mar 2026) | 0.16335 | 44.23 | 0.15905 | 0.1696 | 2 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.48B | -- | 0.48B | 0.49B | 2 |
| FQ3 2027 (Sep 2027) | 0.39B | -- | 0.38B | 0.4B | 2 |
| FQ2 2027 (Jun 2027) | 0.36B | -- | 0.35B | 0.37B | 2 |
| FQ1 2027 (Mar 2027) | 0.36B | -- | 0.36B | 0.36B | 2 |
| FQ4 2026 (Oct 2026) | 0.39B | -- | 0.37B | 0.4B | 2 |
| FQ3 2026 (Jul 2026) | 0.36B | 15.67 | 0.34B | 0.37B | 2 |
| FQ2 2026 (Jun 2026) | 0.39B | 27.52 | 0.38B | 0.41B | 2 |
| FQ1 2026 (Mar 2026) | 0.33B | 23.27 | 0.33B | 0.34B | 4 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
6
EPS # of Misses
1
EPS # of in-lines
1
Revenue # of Beats
7
Revenue # of Misses
1
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 0.15613 | 0.13 | -0.02613 | -20.1% |
| FQ2 2025 (Jun 2025) | 0.11 | 0.11 | 100% | |
| FQ1 2025 (Mar 2025) | 0.0911 | 0.0911 | 100% | |
| FQ4 2024 (Dec 2024) | 0 | 0 | NAN% | |
| FQ3 2024 (Sep 2024) | 0.11 | 0.11 | 100% | |
| FQ2 2024 (Jun 2024) | 0.0759 | 0.0759 | 100% | |
| FQ1 2024 (Mar 2024) | 0.0712 | 0.0712 | 100% | |
| FQ4 2023 (Dec 2023) | 0.17 | 0.17 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.31B | $0.3B | $-8.94M | -2.95% |
| FQ2 2025 (Jun 2025) | $0B | $0.28B | $280.04M | 100% |
| FQ1 2025 (Mar 2025) | $0B | $0.26B | $256.6M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.33B | $330.6M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.28B | $277.87M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.26B | $260.91M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.24B | $237.38M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.31B | $312.37M | 100% |